CD8A and neoplasm: Metformin has been shown to enhance CD8+ T cell activity while reducing immunosuppressive cells, such as regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), promoting a stronger anti-tumor immune response [15].